SCOPUS 정보 검색 플랫폼

Journal of Virology

Volumn 75, Issue 21, 2001, Pages 10300-10308

Yaba-like disease virus: An alternative replicating poxvirus vector for cancer gene therapy

(7) Hu, Y a Lee, J a Andrea McCart, J a Xu, H a Moss, B a Alexander, H R a Bartlett, D L a

a NATIONAL CANCER INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CANCER; CANCER PATIENT; CANCER THERAPY; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS REPLICATION;

ANIMALS; CROSS REACTIONS; FEMALE; GENE THERAPY; GENETIC VECTORS; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; POXVIRIDAE; PROMOTER REGIONS (GENETICS); VACCINIA VIRUS; VIRUS REPLICATION;

EID: 0034785561 PISSN: 0022538X EISSN: None Source Type: Journal
DOI: 10.1128/JVI.75.21.10300-10308.2001 Document Type: Article

Times cited : (38)

References (36)

1
- 0001161923
- An outbreak of subcutaneous tumors in rhesus monkeys
- (1958) Nature , vol.182 , pp. 195-196
- Bearcroft, W.G.C.¹ Jamieson, M.F.²

2
- 0030915310
- Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
- (1997) Proc. Natl. Acad. Sci. USA , vol.94 , pp. 3183-3188
- Bronte, V.¹ Carroll, M.W.² Goletz, T.J.³ Wang, M.⁴ Overwijk, W.W.⁵ Marincola, F.⁶ Rosenberg, S.A.⁷ Moss, B.⁸ Restifo, N.P.⁹

3
- 0022405424
- Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype
- (1985) Nature , vol.317 , pp. 813-815
- Buller, R.M.¹ Smith, G.L.² Cremer, K.³ Notkins, A.L.⁴ Moss, B.⁵

4
- 0030696246
- Poxviruses as expression vectors
- (1997) Curr. Opin. Biotechnol. , vol.8 , pp. 573-577
- Carroll, M.W.¹ Moss, B.²

5
- 0030862430
- Compact, synthetic, vaccinia virus early/late promoter for protein expression
- (1997) BioTechniques , vol.23 , pp. 1094-1097
- Chakrabarti, S.¹ Sisler, J.K.² Moss, B.³

6
- 0033963880
- Human autoantibodies to carcinoembryonic antigen (CEA) induced by a vaccinia-CEA vaccine
- (2000) Clin. Cancer Res. , vol.6 , pp. 34-41
- Conry, R.M.¹ Allen, K.O.² Lee, S.³ Moore, S.E.⁴ Shaw, D.R.⁵ LoBuglio, A.F.⁶

7
- 0024791519
- Structure of vaccinia virus early promoters
- (1989) J. Mol. Biol. , vol.210 , pp. 749-769
- Davison, A.J.¹ Moss, B.²

8
- 0024806798
- Structure of vaccinia virus late promoters
- (1989) J. Mol. Biol. , vol.210 , pp. 771-784
- Davison, A.J.¹ Moss, B.²

9
- 0029986495
- Human cytotoxic T-cell memory: Long-lived responses to vaccinia virus
- (1996) J. Virol. , vol.70 , pp. 2627-2631
- Demkowicz W.E., Jr.¹ Littaua, R.A.² Wang, J.³ Ennis, F.A.⁴

10
- 0015616513
- A comparative study of Tanapox and Yaba viruses
- (1973) J. Gen. Virol. , vol.19 , pp. 37-49
- Downie, A.W.¹ Espana, C.²

11
- 0015221462
- Tanapox: A new disease caused by a pox virus
- (1971) Br. Med. J. , vol.1 , pp. 363-368
- Downie, A.W.¹ Taylor-Robinson, C.H.² Caunt, A.E.³ Nelson, G.S.⁴ Manson-Bahr, P.E.C.⁵ Matthews, T.C.H.⁶

12
- 0000498346
- Expression of proteins in mammalian cells using vaccinia viral vectors
- F. M. Ausubel, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). Greene/Wiley Interscience, New York, N.Y
- (1998) Current protocols in molecular biology , pp. 16151-161811
- Earl, P.L.¹ Moss, B.²

13
- 0015169868
- Review of some outbreaks of viral disease in captive nonhuman primates
- (1971) Lab. Anim. Sci. , vol.21 , pp. 1023-1031
- Espana, C.¹

14
- 0033567895
- Sensitization of tumor necrosis factor alpha (TNFα) resistant human melanoma by tumor specific in vivo transfer of the gene encoding for endothelial monocyte activating polypeptide (EMAP-II) using recombinant vaccinia virus
- (1999) Cancer Res. , vol.59 , pp. 4668-4674
- Gnant, M.¹ Berger, A.C.² Huang, J.³ Puhlmann, M.⁴ Wu, P.C.⁵ Merino, M.J.⁶ Bartlett, D.L.⁷ Alexander H.R., Jr.⁸ Libutti, S.K.⁹

15
- 0033589344
- Tumor-specific gene delivery using recombinant vaccinia virus in a rabbit model of liver metastases
- (1999) J. Natl. Cancer Inst. , vol.91 , pp. 1744-1750
- Gnant, M.F.¹ Noll, L.A.² Irvine, K.R.³ Puhlmann, M.⁴ Terrill, R.E.⁵ Alexander H.R., Jr.⁶ Bartlett, D.L.⁷

16
- 0033565215
- Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor specific gene expression and prolongation of survival in mice
- (1999) Cancer Res. , vol.59 , pp. 3396-3404
- Gnant, M.F.X.¹ Puhlmann, M.² Alexander H.R., Jr.³ Bartlett, D.L.⁴

17
- 0013826696
- Yaba virus infection in humans
- (1965) Exp. Med. Surg. , vol.23 , pp. 213-216
- Grace J.T., Jr.¹ Mirand, E.A.²

18
- 0033571120
- A triad of costimulatory molecules synergize to amplify T-cell activation
- (1999) Cancer Res. , vol.59 , pp. 5800-5807
- Hodge, J.W.¹ Sabzevari, H.² Yafal, A.G.³ Gritz, L.⁴ Lorenz, M.G.⁵ Schlom, J.⁶

19
- 0033831080
- A controlled trial of intratumoral ONHX-015: A selectively replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
- (2000) Nat. Med. , vol.6 , pp. 879-886
- Khuri, F.R.¹ Nemunaitis, J.² Ganly, I.³ Arseneau, J.⁴ Tannock, I.F.⁵ Romel, L.⁶ Gore, M.⁷ Ironside, J.⁸ MacDougall, R.H.⁹ Heise, C.¹⁰ Randlev, B.¹¹ Gillenwater, A.M.¹² Bruso, P.¹³ Kaye, S.B.¹⁴ Hong, W.K.¹⁵ Kirn, D.H.¹⁶

20
- 0024444553
- Studies on tanapox virus
- (1989) Virology , vol.172 , pp. 116-124
- Knight, J.C.¹ Novembre, F.J.² Brown, D.R.³ Goldsmith, C.S.⁴ Esposito, J.J.⁵

21
- 0035866622
- The genome sequence of Yaba-like disease virus, a yatapoxvirus
- (2001) Virology , vol.281 , pp. 170-192
- Lee, H.J.¹ Essani, K.² Smith, G.L.³

22
- 0030728933
- Transient, nonlethal expression of genes in vertebrate cells by recombinant entomopoxviruses
- (1997) J. Virol. , vol.71 , pp. 9557-9562
- Li, Y.¹ Hall, R.L.² Moyer, R.W.³

23
- 0033193127
- Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma
- (1998) Cancer Gene Ther. , vol.6 , pp. 409-422
- Mastrangelo, M.J.¹ Maguire H.C., Jr.² Eisenlohr, L.C.³ Laughlin, C.E.⁴ Monken, C.E.⁵ McCue, P.A.⁶ Kovatich, A.J.⁷ Lattime, E.C.⁸

24
- 0033929022
- Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regression
- (2000) Gene Ther. , vol.7 , pp. 1217-1223
- McCart, J.A.¹ Puhlmann, M.² Lee, J.³ Hu, Y.⁴ Libutti, S.K.⁵ Alexander, H.R.⁶ Bartlett, D.L.⁷

25
- 0024580443
- Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression
- (1989) J. Virol. , vol.63 , pp. 1595-1603
- Merchlinsky, M.¹ Moss, B.²

26
- 0029976870
- Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
- (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 11341-11348
- Moss, B.¹

27
- 0000557448
- Poxviridae: The viruses and their replication
- B. N. Fields, D. M. Knipe, and P. M. Howley (ed.). Lippincott-Raven, Philadelphia, Pa
- (1996) Fields virology , pp. 2637-2671
- Moss, B.¹

28
- 9044232149
- Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
- (1996) Adv. Exp. Med, Biol. , vol.397 , pp. 7-13
- Moss, B.¹ Carroll, M.W.² Wyatt, L.S.³ Bennink, J.R.⁴ Hirsch, V.M.⁵ Goldstein, S.⁶ Elkins, W.R.⁷ Fuerst, T.R.⁸ Lifson, J.D.⁹ Piatak, M.¹⁰ Restifo, N.P.¹¹ Overwijk, W.¹² Chamberlain, R.¹³ Rosenberg, S.A.¹⁴ Sutter, G.¹⁵

29
- 0002663617
- Subcutaneous growths in monkeys produced by a poxvirus
- (1961) J. Pathol. Bacteriol. , vol.81 , pp. 1-14
- Niven, J.S.F.¹ Armstrong, J.A.² Andrewes, C.H.³ Pereira, H.B.⁴ Valentine, R.C.⁵

30
- 0033950819
- Vaccinia as a vector for tumor directed gene therapy. Biodistribution of a thymidine kinase deleted mutant
- (2000) Cancer Gene Ther. , vol.7 , pp. 66-73
- Puhlmann, M.¹ Brown, C.K.² Gnant, M.³ Huang, J.⁴ Libutti, S.K.⁵ Alexander, H.R.⁶ Bartlett, D.L.⁷

31
- 0033105882
- Thymidine kinase deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor directed gene therapy
- (1999) Hum. Gene Ther. , vol.10 , pp. 649-657
- Puhlmann, M.¹ Gnant, M.² Brown, C.K.³ Alexander, H.R.⁴ Bartlett, D.L.⁵

32
- 0032539190
- Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens
- (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1894-1900
- Rosenberg, S.A.¹ Zhair, Y.² Yang, J.C.³ Schwartzentruber, D.J.⁴ Hwu, P.⁵ Marincola, F.M.⁶ Topalian, S.L.⁷ Restifo, N.P.⁸ Seipp, C.A.⁹ Einhorn, J.H.¹⁰ Roberts, B.¹¹ White, D.E.¹²

33
- 0032919654
- Recombinant vaccinia-PSA (Prostvac) can induce a prostate-specific immune response in androgen-modulated human prostate cancer
- (1999) Urology , vol.53 , pp. 260-266
- Sanda, M.G.¹ Smith, D.C.² Charles, L.G.³ Hwang, C.⁴ Pienta, K.J.⁵ Schlom, J.⁶ Milenic, D.⁷ Panicali, D.⁸ Montie, J.E.⁹

34
- 0033199929
- Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating herpes simplex virus vector G207
- (1999) Hum. Gene Ther. , vol.10 , pp. 2237-2243
- Walker, J.R.¹ McGeach, K.G.² Sundaresan, P.³ Jorgensen, T.J.⁴ Rabkin, S.D.⁵ Martoza, R.L.⁶

35
- 0029007260
- Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen
- (1995) J. Immunol. , vol.154 , pp. 4685-4692
- Wang, M.¹ Bronte, V.² Chen, P.W.³ Gritz, L.⁴ Panicali, D.⁵ Rosenberg, S.A.⁶ Restifo, N.P.⁷

36
- 0033556003
- Therapy of colon cancer with oncolytic adenovirus is enhanced by the addition of herpes simplex virus-thymidine kinase
- (1999) Cancer Res. , vol.59 , pp. 410-413
- Wildner, O.¹ Blaese, R.M.² Morris, J.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.